obesity

Arena says FDA accepts new filing for obesity drug lorcaserin, will make decision by June 27
Yahoo/AP
Tue, 01/10/12 - 06:04 pm
Arena
FDA
obesity
lorcaserin
Vivus obesity drug may get broader label
Reuters
Mon, 01/9/12 - 10:30 am
obesity
Vivus
Qnexa
Arena Pharma says it sent the FDA more data on weight-loss drug candidate lorcaserin
Yahoo/AP
Tue, 01/3/12 - 06:55 pm
Arena
obesity
FDA
lorcaserin
EnteroMedics Announces Completion of Patient Enrollment and Device Implantation in the ReCharge Pivotal Trial for Obesity
Wed, 12/28/11 - 04:55 pm
EnteroMedics
patient
clinical trials
obesity
FDA panel to review Qnexa in February 2012
Drug Store News
Fri, 12/23/11 - 08:59 am
FDA
advisory panels
obesity
Qnexa
Vivus
Appetite For Arena Stock May Increase Ahead Of Obesity Drug NDA Re-Submission
Seeking Alpha
Tue, 11/29/11 - 11:38 am
obesity
Arena Pharmaceuticals
lorcaserin
Spatech Develops Obesity Treatment Equipment
Tue, 11/15/11 - 11:00 pm
Spatech
obesity
development
Drug Targeting Fat Cells Caused Significant Weight Loss in Monkeys; Human Trials to Begin Soon
WSJ Online
Thu, 11/10/11 - 12:31 pm
obesity
fat cells
adipotide
Vivus says FDA accepts weight-loss drug application
Reuters
Fri, 11/4/11 - 09:25 am
FDA
obesity
Vivus
Qnexa
Vivus Resubmits Qnexa Obesity Drug After Birth-Defect Warning
Bloomberg
Mon, 10/17/11 - 09:30 am
warnings
Vivus
Qnexa
FDA
obesity
Third Rock seeds a new approach to treating diabetes and obesity
Fierce Biotech
Mon, 10/10/11 - 06:43 pm
Third Rock
diabetes
obesity
Adipothermics
Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss
Yahoo
Mon, 10/3/11 - 11:15 am
Qnexa
obesity
Vivus
A Diet Pill Comeback? Orexigen Revives Its Drug
Pharmalot
Wed, 09/21/11 - 09:26 am
obesity
Orexigen
Contrave
FDA
Arena Pharmaceuticals Shares Popped: What You Need to Know
Motley Fool
Sat, 09/17/11 - 02:52 pm
Arena Pharmaceuticals
Orexigen
Vivus
Qnexa
weight loss
obesity
Vivus plans to resubmit potential diet pill Qnexa to FDA next month
Yahoo/AP
Thu, 09/15/11 - 11:52 am
obesity
Vivus
FDA
Qnexa
Is Arena's Lorcaserin On Track For Approval In 2012?
Seeking Alpha
Mon, 09/12/11 - 09:57 am
Arena
obesity
lorcaserin
Arena's experimental obesity drug lorcaserin beats placebo again
Yahoo/Reuters
Wed, 08/31/11 - 09:43 am
Arena
obesity
lorcaserin
Orexigen Revisited: Chances for Contrave Approval Seem Slim
Seeking Alpha
Wed, 08/10/11 - 05:29 pm
Contrave
Orexigen
obesity
Amylin, Takeda call off obesity treatment
Bloomberg/Businessweek
Fri, 08/5/11 - 01:17 pm
Takeda
pramlintide/metreleptin
obesity
Amylin
Obesity med device maker GI Dynamics files IPO Down Under
Thu, 08/4/11 - 11:53 pm
GI Dynamics
IPOs
obesity

Pages